InMode reports Q1 non-GAAP EPS 52c, consensus 47c

Reports Q1 revenue $106.1M, consensus $101.29M. "As we celebrate the 15th anniversary of the founding of our company, we are pleased to report a strong start to 2023, driven by growing demand for InMode’s procedures. Our unique technology enables patients to achieve effective surgical results while benefiting of minimally invasive procedures," said CEO Moshe Mizrahy. Shakil Lakhani, President of InMode North America, commented, "During the first quarter, we experienced significant growth in consumable sales. Revenue from consumables and service for the first quarter grew nearly 43% year-over-year. This is a strong indication that the platforms we sell are being used more frequently as the demand for our treatments continues to increase." "We have seen an influx of patients seeking treatment following the use of popular weight loss drugs. InMode’s technology can effectively assist patients in tightening the loose skin post the effects of these medications," said Spero Theodorou, Chief Medical Officer.